[1]
“Safety Evaluation of EGFR-TKI Therapy in Patients with Non-Small Cell Lung Cancer: A Real-World Study Based on theFAERS Database”, CMP, vol. 3, no. 2, pp. 1–13, Mar. 2026, doi: 10.70731/0yk94f55.